Clinical trial reportNature medicinePublished
Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trial
12 of 42 authors shown in byline order.
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Nature medicine
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Multiple Myeloma; Neoplasm, Residual; Immunotherapy, Adoptive; Aged; Middle Aged; Female; Male; Smoldering Multiple Myeloma; Receptors, Chimeric Antigen
- PubMed ID
- 42010117
- PubMed Central ID
- PMC13375535
- Open access
- Yes, open
- Added to directory
- Source checked